Immunic, Inc. - Common Stock (NQ:IMUX)

7.370 +0.050 (+0.68%)

Delayed Quote Updated: 9:45 AM EST, Nov 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Immunic, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Immunic Plans Phase 3 Progressive MS Trial After Mixed Phase 2 Results ↗

Today 0:14 EST

Immunic (NASDAQ:IMUX) is preparing a Phase 3 trial of its experimental multiple sclerosis drug vidofludimus calcium in progressive disease, with the first patients expected to enroll in the first half...

Via MarketBeat

Stock Market Today, March 24: Oil, AI, and Private Credit Fears Weigh on Markets ↗

March 24, 2026

On March 24, 2026, choppy, oil-driven trading and fresh AI disruption fears pressured major U.S. indexes.

Via The Motley Fool

Which stocks have an unusual volume on Tuesday? ↗

February 17, 2026

Via Chartmill

Immunic Stock Jumps After Pricing $400 Million Private Placement ↗

February 13, 2026

Immunic Inc (NASDAQ:IMUX) is surging Friday after the late‑stage biotech announced a private placement of up to $400 million.

Via Benzinga

Traders are paying attention to the gapping stocks in Friday's session. ↗

February 13, 2026

Via Chartmill

What's going on in today's pre-market session ↗

February 13, 2026

Via Chartmill

Why Did IMUX Stock Surge 33% Pre-Market Today? ↗

February 13, 2026

Immunic announced a private placement of up to $400 million to support its clinical studies and other operational needs.

Via Stocktwits

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

November 18, 2025

Via Benzinga

This Electronic Arts Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday ↗

September 29, 2025

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings...

Via Benzinga

This VSE Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗

September 29, 2025

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings...

Via Benzinga

Immunic (IMUX) Q2 Loss Widens 25% ↗

August 07, 2025

Via The Motley Fool

Immunic Announces Vidofludimus Calcium Reduced Risk of Disability Worsening by 30% in Primary Progressive Multiple Sclerosis Patients from Phase 2 CALLIPER Trial ↗

July 07, 2025

Via Stocktwits

Immunic to Participate in Scientific and Industry Conferences in May ↗

July 07, 2025

Via Stocktwits

Topics Economy

Immunic, Inc. Announces Proposed Public Offering ↗

July 07, 2025

Via Stocktwits

Topics Regulatory Compliance

Immunic, Inc. Announces Pricing of Oversubscribed $65 Million Underwritten Public Offering ↗

July 07, 2025

Via Stocktwits

Immunic to Participate in Investor, Scientific and Industry Conferences in June ↗

July 02, 2025

Via Stocktwits

Topics Intellectual Property

Immunic, Inc. Announces Closing of Oversubscribed $65 Million Underwritten Public Offering ↗

July 02, 2025

Via Stocktwits

Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Relapsing MS and Presents Additional Data Underlining Positive Outcome of Phase 2 CALLIPER Trial in Progressive MS ↗

July 02, 2025

Via Stocktwits

Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis ↗

July 02, 2025

Via Stocktwits

Let's take a look at the stocks that are in motion in today's session. ↗

May 29, 2025

Stay up-to-date with the latest market trends one hour before the close of the markets on Thursday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 29, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

May 28, 2025

Via Benzinga

Wednesday's session: top gainers and losers ↗

April 30, 2025

Intrigued by the market activity one hour before the close of the markets on Wednesday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

April 30, 2025

Via Benzinga

Wednesday's session: gap up and gap down stocks ↗

April 30, 2025

The session on Wednesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Via Chartmill

These stocks that are showing activity before the opening bell on Wednesday. ↗

April 30, 2025

Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top gainers and losers in today's pre-market session.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 30, 2025

Via Benzinga

Immunic Stock Draws Investor Attention On $5.1M Registered Direct Offering: Retail’s On Wait-And-Watch Mode ↗

April 09, 2025

Immunic intends to use the net proceeds from the proposed offering to fund its clinical trials and operations and for other general corporate purposes.

Via Stocktwits

Topics Intellectual Property Lawsuit

Immunic to Present at the November 21st Virtual Investor Summit Microcap Event

November 11, 2024

Via ACCESSWIRE

This Yelp Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday ↗

September 16, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.